We are live on
!
Find out more
AA
AlphaCentric Advisors Portfolio holdings
AUM
$118M
This Fund
S&P 500
This Quarter
Est. Return
+2.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$297M
AUM Growth
+$56.9M
(+24%)
Cap. Flow
+$55.4M
Cap. Flow
% of AUM
18.67%
Top 10 Holdings %
Top 10 Hldgs %
80.3%
Holding
232
New
27
Increased
80
Reduced
67
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MBS ETF
MBB
|
+$25.2M |
| 2 |
Invitation Homes
INVH
|
+$6.9M |
| 3 |
American Homes 4 Rent
AMH
|
+$3.4M |
| 4 |
LAZR
Luminar Technologies
LAZR
|
+$1.51M |
| 5 |
LKFT
Lakefront Biotherapeutics American Depositary Shares
LKFT
|
+$1.34M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Globus Medical
GMED
|
+$978K |
| 2 |
Omnicell
OMCL
|
+$641K |
| 3 |
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
|
+$568K |
| 4 |
RAVN
Raven Industries Inc
RAVN
|
+$373K |
| 5 |
NNDM
Nano Dimension
NNDM
|
+$287K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Real Estate | 18.29% |
| 2 | Healthcare | 13.15% |
| 3 | Technology | 2% |
| 4 | Industrials | 1.37% |
| 5 | Consumer Discretionary | 1.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAV
176
DELISTED
Pioneer Municipal High Income Advantage Fund
MAV
| $74K | 0.03% |
+6,266
| New | +$73.7K |
|
|
MYJ
177
DELISTED
Blackrock Muni Yield New Jersey Fund, Inc.
MYJ
| $67K | 0.02% |
4,590
+2,690
| +142% | +$39K |
|
178
Agilent Technologies
A
$39.1B
| $66K | 0.02% |
519
-17
| -3% | -$2.1K |
|
179
Monster Beverage
MNST
$91.4B
| $62K | 0.02% |
1,364
-46
| -3% | -$2.06K |
|
180
BlackRock MuniHoldings New Jersey Quality Fund
MUJ
$640M
| $61K | 0.02% |
+4,078
| New | +$59.7K |
|
181
Idexx Laboratories
IDXX
$42.9B
| $59K | 0.02% |
120
-4
| -3% | -$2K |
|
182
Tyler Technologies
TYL
$12.2B
| $58K | 0.02% |
136
-4
| -3% | -$1.73K |
|
183
Amazon
AMZN
$2.5T
| $56K | 0.02% |
360
-20
| -5% | -$3.17K |
|
184
Charter Communications
CHTR
$14.7B
| $54K | 0.02% |
87
-3
| -3% | -$1.88K |
|
185
West Pharmaceutical
WST
$23.1B
| $54K | 0.02% |
192
-7
| -4% | -$2K |
|
186
Eli Lilly
LLY
$1.07T
| $53K | 0.02% |
283
-9
| -3% | -$1.76K |
|
187
Revvity
RVTY
$12.3B
| $53K | 0.02% |
411
-14
| -3% | -$1.94K |
|
188
Danaher
DHR
$135B
| $52K | 0.02% |
259
-9
| -3% | -$1.83K |
|
189
Costco
COST
$415B
| $51K | 0.02% |
145
-1
| -0.7% | -$348 |
|
190
Thermo Fisher Scientific
TMO
$211B
| $51K | 0.02% |
112
-4
| -3% | -$1.91K |
|
191
Dollar General
DG
$25.9B
| $49K | 0.02% |
244
-8
| -3% | -$1.59K |
|
|
MFT
192
DELISTED
BLACKROCK MUNIYIELD INVESTMENT QUALITY FUND
MFT
| $49K | 0.02% |
+3,400
| New | +$49.3K |
|
193
AbbVie
ABBV
$458B
| $46K | 0.02% |
425
| – | – |
|
194
Rollins
ROL
$18.6B
| $46K | 0.02% |
1,348
-43
| -3% | -$1.54K |
|
195
Walmart Inc
WMT
$871B
| $46K | 0.02% |
1,008
-30
| -3% | -$1.39K |
|
196
Bristol-Myers Squibb
BMY
$127B
| $45K | 0.02% |
710
| – | – |
|
197
Campbell Soup
CPB
$6.51B
| $45K | 0.02% |
887
-13
| -1% | -$619 |
|
198
Clorox
CLX
$11.6B
| $44K | 0.01% |
230
-7
| -3% | -$1.35K |
|
199
Akamai
AKAM
$16.8B
| $43K | 0.01% |
418
-14
| -3% | -$1.45K |
|
|
CTXS
200
DELISTED
Citrix Systems Inc
CTXS
| $41K | 0.01% |
290
-9
| -3% | -$1.21K |
|
Similar funds
AIS
IVGAI
OIM
TIP
RCG
CWM
SPW
WLC
AlphaCentric Advisors's Q1 2021 Portfolio in Review
As of Q1 2021, AlphaCentric Advisors held 232 positions worth $297M, up 24% from $240M the previous quarter. Its ten largest holdings account for 80% of the portfolio.
AlphaCentric Advisors deployed $55.4M of net new capital in Q1 2021, opening 27 new positions and adding to 80 existing holdings. Its largest new stake was Luminar Technologies: 3,333 shares worth $1.22M.
By sector, the portfolio is most concentrated in Real Estate at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Omnicell, an estimated $641K trimmed.
- AlphaCentric Advisors's largest Q1 2021 buy was Luminar Technologies: 3,333 shares worth $1.22M.
- AlphaCentric Advisors added most to iShares MBS ETF in Q1 2021, an estimated $25.2M increase.
- AlphaCentric Advisors's biggest Q1 2021 reduction was Omnicell, cutting an estimated $641K.
- AlphaCentric Advisors fully exited Globus Medical in Q1 2021, selling an estimated $978K.
- AlphaCentric Advisors's ten largest holdings make up 80% of its $297M portfolio in Q1 2021.
- AlphaCentric Advisors opened 27 new positions and closed 26 in Q1 2021.
- AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $297M.
Based on AlphaCentric Advisors's 13F filing for Q1 2021, filed 9 Mar 2022.